fbpx

New Partner joins Lundbeckfonden Emerge

Andreas Jurgeit is to join Lundbeckfonden Emerge, the early stage investment unit of the Lundbeck Foundation, as a partner on 1 January 2019.

Andreas has been active in various operational and financing roles over the last decade. He was first exposed to biotech as a scientist collaborating with 3V Biosciences during his PhD and later joined Zurich-based venture investor Redalpine as Investment Manager. Most recently, as Director of the Merck Ventures Life Science team, he has conducted investments globally, with portfolio companies and board mandates in Europe, the US and Israel.

Andreas is 37 years old and is originally from Austria. He holds degrees in Molecular Biology from the University of Innsbruck and a PhD in Virology from the University of Zurich.

News

Maude has become the stereotypical migraine patient – but it’s not quite the true picture
31. July 2020
Ancient DNA throws a ‘scientific hand grenade’ into the discussion about the arrival of humans in North America
23. July 2020
Danish researchers map key disease mechanism – and describe a completely new protein
20. July 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge